Evidence map›Paper›PMID 28849308›Full record

ArticleLa Radiologia medica2017

18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.

Rosario Mazzola, Pierpaolo Alongi, Francesco Ricchetti, Alba Fiorentino, Sergio Fersino, Niccolò Giaj-Levra, Matteo Salgarello, Filippo Alongi

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Impact of pretreatment second lookClinical and translational radiation oncology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rosario MazzolaRadiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy. rosariomazzola@hotmail.it.
Pierpaolo AlongiNuclear Medicine, Fondazione Giglio, Cefalù, Italy.
Francesco RicchettiRadiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Alba FiorentinoRadiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Sergio FersinoRadiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Niccolò Giaj-LevraRadiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Matteo SalgarelloNuclear Medicine, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Filippo AlongiRadiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Ospedale Sacro Cuore Don Calabria · ITFondazione Istituto G. Giglio di Cefalù · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo analyze the impact of 18F-fluorodeoxyglucose-PET/CT (PET/CT) in the radiotherapy (RT) planning strategy in HNC, correlating CT-scan and PET/CT performances. MATERIALS AND

methodsInclusion criteria were: age >18 years old, histologically proven head and neck cancer (HNC), patients candidate to definitive RT ± chemotherapy, stage of disease by means of PET/TC and CT-scan performed at our Cancer Care Center.

resultsSixty patients were analyzed. The following primary tumor sites were investigated: nasopharynx (13%), oropharynx (42%), oral cavity (32%) and larynx non-glottic (13%). Globally, PET/CT findings caused changes on nodal radiation treatment volumes in 10% of all the population of study. Specifically, in 5 cases out of 19 oral cavity tumors (26%), PET/CT detected neck-nodes positive (not detected at CT-scan). These findings have allowed to change the patients management, including PET/CT neck-nodes positive in the high-risk RT volumes.

conclusionIn the RT planning strategy, the present findings support the use of PET/CT to improve upfront regional staging of HNC disease, particularly for oral cavity tumors. Further investigations are advocated to evaluate if this strategy could impact on long-term outcomes in terms of local control and overall survival.

Indexed as

Positron Emission Tomography Computed TomographyAgedCombined Modality TherapyFemaleFluorodeoxyglucose F18Head and Neck NeoplasmsHumansLymphatic MetastasisMagnetic Resonance ImagingMaleMiddle AgedNeoplasm StagingRadiopharmaceuticalsRadiotherapy Planning, Computer-AssistedFluorodeoxyglucose F18RadiopharmaceuticalsFluorodeoxyglucose-PET/CTLocally advanced head and neck cancerRadiotherapy

Identifiers

PMID28849308
OpenAlexW2745510548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.